A Placebo-Controlled Study of Galcanezumab in Patients with Episodic Cluster Headache: Results from the 8-Week Double-Blind Treatment Phase

被引：0
|
作者：
Bardos, Jennifer N. [1 ]
Goadsby, Peter J. [2 ,3 ]
Dodick, David [4 ]
Leone, Massimo [5 ]
Oakes, Tina M. [1 ]
Martinez, James M. [1 ]
Millen, Brian A. [1 ]
Zhou, Chunmei [1 ]
Dowsett, Sherie A. [1 ]
Aurora, Sheena K. [1 ]
Yang, Jyun Yan [1 ]
Conley, Robert [1 ,6 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Kings Coll London, NIHR Wellcome Trust Kings Clin Res Facil, London, England
[4] Mayo Clin, Phoenix, AZ USA
[5] IRCCS Fdn Carlo Besta Neurol Inst, Milan, Italy
[6] Univ Maryland, Sch Med, Indianapolis, IN USA
来源：
NEUROLOGY | 2019年 / 92卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Plen02.004
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Study CGAL: a placebo-controlled study of galcanezumab in patients with episodic cluster headache: results from the 8-week double-blind treatment phase
    Martinez, James M.
    Goadsby, Peter J.
    Dodick, David
    Bardos, Jennifer N.
    Oakes, Tina M. Myers
    Millen, Brian A.
    Zhou, Chunmei
    Dowsett, Sherie A.
    Aurora, Sheena K.
    Yang, Jyun Yan
    Conley, Robert R.
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [2] STUDY CGAL: A PLACEBO-CONTROLLED STUDY OF GALCANEZUMAB IN PATIENTS WITH EPISODIC CLUSTER HEADACHE: RESULTS FROM THE 8-WEEK DOUBLE-BLIND TREATMENT PHASE
    Martinez, J. M.
    Goadsby, P. J.
    Dodick, D. W.
    Bardos, J. N.
    Oakes, T. M. Myers
    Millen, B. A.
    Zhou, C.
    Dowsett, S. A.
    Aurora, S.
    Yang, J. Y.
    Conley, R. R.
    CEPHALALGIA, 2018, 38 : 145 - 146
  • [3] Study CGAL: A Phase 3 Placebo-Controlled Study of Galcanezumab in Patients with Episodic Cluster Headache: Results from the 8-Week Double-Blind Treatment Phase
    Martinez, James M.
    Goadsby, Peter
    Dodick, David
    Bardos, Jennifer N.
    Oakes, Myers Tina M.
    Millen, Brian A.
    Zhou Chunmei
    Dowsett, Sherie A.
    Aurora, Sheena K.
    Conley, Robert R.
    Yang, Jyun Yan
    HEADACHE, 2018, 58 (08): : 1289 - 1290
  • [4] Phase 3 Placebo-Controlled Study of Galcanezumab in Patients with Chronic Cluster Headache: Results from 3-Month Double-Blind Treatment
    Oakes, T. M.
    Dodick, D. W.
    Goadsby, P. J.
    Lucas, C.
    Jensen, R.
    Bardos, J.
    Martinez, J.
    Zhou, C.
    Aurora, S. K.
    Yang, J.
    Conley, R.
    HEADACHE, 2019, 59 : 19 - 20
  • [5] Post-hoc outcomes from a Phase 3 randomized, double-blind, placebo-controlled study of galcanezumab in patients with episodic cluster headache
    Kudrow, David
    Oakes, Tina
    Bardos, Jennifer
    Andrews, J. Scott
    Rettiganti, Mallikarjuna
    Zhou, Chunmei
    Riesenberg, Robert
    Wenzel, Richard
    Kuruppu, Dulanji
    Martinez, James
    CEPHALALGIA, 2019, 39 : 60 - 60
  • [6] Post-hoc Outcomes from a Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients with Episodic Cluster Headache
    Kudrow, D.
    Oakes, T. M.
    Bardos, J.
    Andrews, J.
    Rettiganti, M.
    Zhou, C.
    Riesenberg, R.
    Wenzel, R.
    Kuruppu, D.
    Martinez, J.
    HEADACHE, 2019, 59 : 193 - 193
  • [7] Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment
    Dodick, David W.
    Goadsby, Peter J.
    Lucas, Christian
    Jensen, Rigmor
    Bardos, Jennifer N.
    Martinez, James M.
    Zhou, Chunmei
    Aurora, Sheena K.
    Yang, Jyun Yan
    Conley, Robert R.
    Oakes, Tina
    CEPHALALGIA, 2020, 40 (09) : 935 - 948
  • [8] Impact of galcanezumab on total pain burden: findings from a Phase 3 randomized, double-blind, placebo-controlled study in patients with episodic cluster headache
    Kudrow, David
    Andrews, Scott
    Rettiganti, Mallikarjuna
    Oakes, Tina
    Bardos, Jennifer N.
    Wenzel, Richard
    Kuruppu, Dulanji
    Gaul, Charly
    Martinez, James
    Aurora, Sheena
    CEPHALALGIA, 2019, 39 : 62 - 62
  • [9] Impact of Galcanezumab on Total Pain Burden: Findings from a Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Patients with Episodic Cluster Headache
    Kudrow, D.
    Andrews, J.
    Rettiganti, M.
    Oakes, T. M.
    Bardos, J.
    Wenzel, R.
    Kuruppu, D.
    Gaul, C.
    Martinez, J.
    Aurora, S.
    HEADACHE, 2019, 59 : 183 - 183
  • [10] A phase 3 placebo-controlled study of galcanezumab in patients with episodic migraine: Results from the 3-month double-blind treatment phase of the PERSIST study
    Yu, S.
    Hu, B.
    Li, G.
    Jia, Z.
    Chowdhury, D.
    Zhuang, J.
    Qian, C.
    HEADACHE, 2022, 62 : 130 - 131
12345